The FDA has long been criticized for its "revolving door" with Big Pharma where top executives move back and forth in top positions. The case of FDA approval of BioNTech's Comirnaty gene therapy injection abandoned all traditional precedents in pushing it through: incomplete data and trials, insufficient control group and no review board.
Technocracy News & Trends Premium Services are for Premium Access members only. Check it out!
Patrick Wood is a leading and critical expert on Sustainable Development, Green Economy, Agenda 21, 2030 Agenda and historic Technocracy. He is the author of Technocracy Rising: The Trojan Horse of Global Transformation (2015) and co-author of Trilaterals Over Washington, Volumes I and II (1978-1980) with the late Antony C. Sutton.
